Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.
Where this comes from
- Record sourced from PubMed, PMID 30177852.
- Also identified by DOI 10.1038/s41436-018-0264-5 and PMC identifier 7608196.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the original version of this Article, the affiliation details for Personalized Medicine & Targeted Therapeutics, USA were incorrectly given as Personalized Medicine & Targeted Therapeutics, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA. This has now been corrected in both the PDF and HTML versions of the Article.